Etiket: Grifols
The funds that bet on the downside return to the attack on Grifols
Los fondos bajistas han vuelto al ataque en Grifols. El jueves, tras un mes de subidas de las acciones de la multinacional de hemoderivados se dieron un festín con el…
Grifols sues in the US against the bearish fund that sank it in the stock market and demands financial compensation
Grifols has initiated legal action against Gotham City in the United States, as reported by the company in a relevant fact sent to the CNMV this Friday after the market…
Grifols suffers a new bearish attack in the midst of the Gotham commotion
The bottom Millennium International Management has decided to reopen a short position on Grifols equivalent to 0.53% of its capital, after several days in which the value has been affected…
Grifols guarantees that the sale of its Chinese company to Haier continues
The Catalan multinational Grifols wanted to make it clear this Sunday that the bearish firm’s report Gotham City Research will not affect the sale of 20% of its Chinese subsidiary…
The ‘tunnel transactions’ to Scranton, the key to the Grifols case
The Grifols case, that is, the devastating effect of the report by the British firm Gotham City, supposedly uncovering accounting makeup in the accounts of the Catalan family company, cannot…
Doubts about Grifols… and a certainty
The report published yesterday by the bearish fund Gotham City Research that accuses Grifols of manipulating the accounting caused an earthquake in the stock market. The shares of the pharmaceutical…
Grifols, plasma and the diversification of 2021 as the background of all evils
He plasma. That is the origin of everything and its lack of supply is the cause of the complex evolution of the Catalan firm Grifols in recent years. The year…
Grifols holds a conference this Wednesday with investors to refute the theses of Gotham City Research
Grifols plans to hold a conference tomorrow, Wednesday telephone with investors with the objective to refute the Gotham City Research accusationsaccording to analysts from Banco Santander and Citi cited by…
Glanzmann assumes full power at Grifols
Thomas Glanzmanthe CEO of grifols, will control all the power in the company by also being appointed CEO. The blood derivatives multinational has decided that this director from outside the…
Grifols plans to lay off 2,300 employees, a hundred of them in Spain
The Spanish multinational blood products grifols announced this Wednesday that it will launch a cost savings plan, to reduce spending by 400 million per yearwhat includes the dismissal of 2,300…